GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeiGene Ltd (HKSE:06160) » Definitions » E10

BeiGene (HKSE:06160) E10 : HK$-7.19 (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BeiGene E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BeiGene's adjusted earnings per share data for the three months ended in Dec. 2024 was HK$-0.855. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is HK$-7.19 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-30), BeiGene's current stock price is HK$161.60. BeiGene's E10 for the quarter that ended in Dec. 2024 was HK$-7.19. BeiGene's Shiller PE Ratio of today is .


BeiGene E10 Historical Data

The historical data trend for BeiGene's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeiGene E10 Chart

BeiGene Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -7.18 -7.19

BeiGene Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.18 -7.25 -7.14 -7.70 -7.19

Competitive Comparison of BeiGene's E10

For the Biotechnology subindustry, BeiGene's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BeiGene's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeiGene's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BeiGene's Shiller PE Ratio falls into.


;
;

BeiGene E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BeiGene's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.855/133.1571*133.1571
=-0.855

Current CPI (Dec. 2024) = 133.1571.

BeiGene Quarterly Data

per share eps CPI Adj_EPS
201503 -0.113 99.621 -0.151
201506 -0.063 100.684 -0.083
201509 -0.155 100.392 -0.206
201512 -0.515 99.792 -0.687
201603 -0.543 100.470 -0.720
201606 -0.466 101.688 -0.610
201609 -0.621 101.861 -0.812
201612 -0.566 101.863 -0.740
201703 -0.777 102.862 -1.006
201706 -0.936 103.349 -1.206
201709 1.563 104.136 1.999
201712 -1.311 104.011 -1.678
201803 -1.255 105.290 -1.587
201806 -1.726 106.317 -2.162
201809 -1.489 106.507 -1.862
201812 -2.737 105.998 -3.438
201903 -1.727 107.251 -2.144
201906 -0.861 108.070 -1.061
201909 -3.056 108.329 -3.756
201912 -3.824 108.420 -4.696
202003 -2.809 108.902 -3.435
202006 -2.558 108.767 -3.132
202009 -2.868 109.815 -3.478
202012 -3.101 109.897 -3.757
202103 0.388 111.754 0.462
202106 -3.122 114.631 -3.627
202109 -2.827 115.734 -3.253
202112 -3.666 117.630 -4.150
202203 -2.582 121.301 -2.834
202206 -3.296 125.017 -3.511
202209 -3.218 125.227 -3.422
202212 -2.569 125.222 -2.732
202303 -2.041 127.348 -2.134
202306 -2.193 128.729 -2.268
202309 1.174 129.860 1.204
202312 -2.109 129.419 -2.170
202403 -1.486 131.776 -1.502
202406 -0.703 132.554 -0.706
202409 -0.701 133.029 -0.702
202412 -0.855 133.157 -0.855

Add all the adjusted EPS together and divide 10 will get our e10.


BeiGene  (HKSE:06160) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BeiGene E10 Related Terms

Thank you for viewing the detailed overview of BeiGene's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BeiGene Business Description

Traded in Other Exchanges
Address
c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman, CYM, KY1-1108
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
Executives
Jpmorgan Chase & Co. 2502 Approved lending agent
Oyler John Victor 2101 Beneficial owner
Hhlr Advisors, Ltd. 2102 Investment manager
Hhlr Fund, L.p. 2101 Beneficial owner
Baker Brothers Life Sciences Capital, L.p. 2201 Interest of corporation controlled by you
Baker Felix James 2201 Interest of corporation controlled by you
Baker Julian Charles 2201 Interest of corporation controlled by you
Baker Bros. Advisors (gp) Llc 2201 Interest of corporation controlled by you
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
Amgen Inc. 2101 Beneficial owner
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner
Fidelity Management & Research Company
Fmr Co., Inc.

BeiGene Headlines

No Headlines